These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7587707)

  • 1. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
    Frey T; Yue S; Haugland RP
    Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?
    Denis-Gay M; Petit JM; Ratinaud MH
    Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
    Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
    Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.
    Dordal MS; Ho AC; Jackson-Stone M; Fu YF; Goolsby CL; Winter JN
    Cytometry; 1995 Aug; 20(4):307-14. PubMed ID: 7587718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of multidrug resistance by fluorescent dyes.
    Kessel D; Beck WT; Kukuruga D; Schulz V
    Cancer Res; 1991 Sep; 51(17):4665-70. PubMed ID: 1873811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies.
    Tatu CA; Paunescu V; Stanescu DI; Schneider F
    Anticancer Res; 1997; 17(4A):2583-6. PubMed ID: 9252684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
    Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
    Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
    Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
    Lautier D; Canitrot Y; Salmon JM
    Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
    Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
    Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
    Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
    Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
    Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
    De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
    Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
    Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
    Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
    Ghetie MA; Ghetie V; Vitetta ES
    Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidrug resistance of leukemia cells to cytostatics--the functional fluorescent dye efflux assay evaluated by flow cytometry].
    Jankovicová K; Krejsek J; Kopecký O
    Vnitr Lek; 2001 Jan; 47(1):25-9. PubMed ID: 15635865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.